The 85th Annual Meeting of the Japanese Cancer Association

Ethical Guidelines

The Japanese Cancer Association requires presenters to declare that their submitted abstracts have undergone appropriate ethical review in accordance with the applicable research ethics regulations.

Depending on the content of the abstracts, even if approval by authors’ institutional review boards (IRB) or equivalent committees is deemed unnecessary, please refer to the “Ethical Guidelines” below and make a declaration where required.

Please note that abstracts may be rejected or not accepted if no ethical declaration is made or if appropriate institutional approval has not been obtained.

For terminology, please refer to the “Ethical Guidelines for Life Science and Medical Research Involving Human Subjects” (promulgated on March 23, 2021; partially revised on March 27, 2023) issued by Ministry of Education, Culture, Sports, Science and Technology, Ministry of Health, Labour and Welfare, and Ministry of Economy, Trade and Industry of Japan　（https://www.mext.go.jp/content/20250325-mxt_life-000035486-01.pdf）.

Ethical Declaration Items at Abstract Submission

1. Does your abstract involve research using samples or information obtained from human subjects?
   Note that commercially available human-derived cell lines and commercially available nucleic acid samples are not considered “samples obtained from human subjects.”
2. Does your abstract fall into any of the following categories?

   o Reports or studies involving neither intervention nor invasion (e.g., observational studies, epidemiological studies)

   o Reports or studies involving intervention

   o Reports or studies involving invasion

   o Reports or studies involving unapproved or off-label drugs or medical practices

3. Has your abstract been reviewed and approved by an ethics review committee or equivalent body in accordance with the applicable research ethics regulations?
4. Which laws, regulations, or ethical guidelines applicable to your abstract are relevant?
5. Has your study been registered with any of the following clinical trial registries?

   o University Hospital Medical Information Network (UMIN) Clinical Trials Registry

   o Japan Pharmaceutical Information Center (JapicCTI)

   o Japan Medical Association Clinical Trial Registry

   o Ministry of Health, Labour and Welfare (MHLW) jRCT (Japan Registry of Clinical Trials) system for registration and public disclosure of clinical research implementation plans and study summaries?

   o ClinicalTrials.gov